{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "23528494", "DateCompleted": {"Year": "2013", "Month": "08", "Day": "22"}, "DateRevised": {"Year": "2016", "Month": "10", "Day": "18"}, "Article": {"Language": ["rus"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "1997-7298", "JournalIssue": {"Volume": "113", "Issue": "1", "PubDate": {"Year": "2013"}}, "Title": "Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova", "ISOAbbreviation": "Zh Nevrol Psikhiatr Im S S Korsakova"}, "ArticleTitle": "[The efficiency of cytoflavin and ozonotherapy in complex treatment of the myasthenia].", "Pagination": {"StartPage": "46", "EndPage": "49", "MedlinePgn": "46-9"}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Drozd", "ForeName": "O A", "Initials": "OA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Efremov", "ForeName": "V V", "Initials": "VV"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Dudarev", "ForeName": "I V", "Initials": "IV"}], "PublicationTypeList": ["Controlled Clinical Trial", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Russia (Federation)", "MedlineTA": "Zh Nevrol Psikhiatr Im S S Korsakova", "NlmUniqueID": "9712194", "ISSNLinking": "1997-7298"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drug Combinations"}, {"RegistryNumber": "0", "NameOfSubstance": "Succinates"}, {"RegistryNumber": "0", "NameOfSubstance": "cytoflavin"}, {"RegistryNumber": "25X51I8RD4", "NameOfSubstance": "Niacinamide"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "7N464URE7E", "NameOfSubstance": "Flavin Mononucleotide"}, {"RegistryNumber": "86-04-4", "NameOfSubstance": "Inosine Diphosphate"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Combined Modality Therapy"}, {"QualifierName": [], "DescriptorName": "Drug Combinations"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Flavin Mononucleotide"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Inosine Diphosphate"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Myasthenia Gravis"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Niacinamide"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Succinates"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": [], "DescriptorName": "Young Adult"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2013", "Month": "3", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2013", "Month": "3", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2013", "Month": "8", "Day": "24", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["23528494"]}}], "PubmedBookArticle": []}